Clin2
NCT07219277Likely a fitRecruiting

Blood test to detect breast cancer early in women

Breast Cancer, Liquid Biopsy, Early Detection

Part of Cancer, Skin clinical trials.

This study tests a new blood test that aims to find breast cancer early in women who are at higher risk or are going for routine screening. If you are a woman aged 30–75 and are scheduled for a mammogram, MRI, or breast ultrasound, you may be able to help validate this test.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,000 people
Ages
30 years to 75 years
Study type
Observational

Who can take part

  • You are a woman between 30 and 75 years old.
  • You are planning a routine breast screening (like a mammogram or MRI) or have been asked to come back for more imaging or a biopsy.
  • You are not currently having any breast symptoms (like a lump or pain) or have not been diagnosed with breast cancer.
  • You have not had breast surgery or a breast biopsy in the past year.
  • You have not had any cancer in the past except for some types of skin cancer.
  • You have not had a blood transfusion in the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06876610Recruiting
Blood test for early breast cancer detection

This trial tests a blood test that looks for chemical changes in DNA to help diagnose breast cancer. It may offer a simpler way to detect cancer without needing a tissue sample.

Beijing, Beijing Municipality
NCT06439940Recruiting
Early breast cancer detection with blood test

This study tests a new blood test (liquid biopsy) that looks for tiny molecules called microRNAs to find early signs of breast cancer. It aims to detect cancer before symptoms appear, using a simple blood draw during your regular mammogram visit.

El Palomar, Morón, Buenos Aires
NCT06336928Recruiting
Blood test validation for breast cancer diagnosis

This study is testing a new blood test (liquid biopsy) to see if it can accurately detect breast cancer or track remission. If you are a woman getting a mammogram, have an abnormal finding, were recently diagnosed, or are in remission after treatment, you may be able to join and help validate this test.

Los Angeles, California
NCT04353557Recruiting
Blood test monitoring in early-stage breast cancer

This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.

Chongqing, Chongqing Municipality
NCT07046260Recruiting
Blood test study for early cancer detection

This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.

Coronado, California
NCT07331506Recruiting
Early detection of breast cancer with a blood test

This trial tests a new blood test called Oncoliq to see if it can find breast cancer early. It compares results from people with breast cancer and people without cancer.

Buenos Aires, Buenos Aires

Hear when a new Breast Cancer, Liquid Biopsy, Early Detection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.